MG’s – or rather SAIC Motor’s – approach comes in the form of two electric cars: the IM5 hatchback and the IM6 SUV this review deals with.

Sun Pharmaceutical Industries Limited announced top-line results from two phase 3 clinical studies evaluating the efficacy and safety of tildrakizumab 100 mg (Ilumya) administered over 24 weeks for ...

MG has revealed the IM5 saloon and IM6 SUV at Goodwood as MG goes more upmarket and aims to tackle the Tesla Model 3 and Tesla Model Y.

MG is set to unveil a new model that will rival the Tesla Model Y. The launch will take place at the Goodwood Festival of Speed. MG posted a teaser image on social media stating that “all will be ...

The phase diagram has a closed-loop binodal (as in associative phase diagrams) with two critical points. One critical point is in common with the strong driving force cases, that is, the system loses ...

Post-chemotherapy administration of 5 mg olanzapine in combination with triplet antiemetic therapy before anthracycline plus cyclophosphamide-based chemotherapy significantly improved the complete ...

Olema Pharmaceuticals selects 90 mg palazestrant for Phase 3 trials targeting metastatic breast cancer, with results expected in 2026.

A phase 1a/1b trial in relapsed/refractory T-cell non-Hodgkin lymphoma to determine the safety profile, pharmacology, and maximum tolerated dose of ST-001, an intravenous fenretinide phospholipid ...

The tuspetinib-based TUS+VEN+AZA triplet therapy is being advanced in the TUSCANY Phase 1/2 trial with the goal of creating an improved frontline therapy for newly diagnosed AML patients that is ...

In the current ongoing phase 3 trial, we found evidence for the superiority of semaglutide over placebo for histologic reductions in steatohepatitis and fibrosis.

About ATH434-201 Phase 2 Clinical Trial The ATH434-201 Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of 12 months treatment with ATH434 in patients with MSA.